Literature DB >> 24388623

Characteristics, management, and outcomes of cocaine-positive patients with acute coronary syndrome (from the National Cardiovascular Data Registry).

Navdeep Gupta1, Jeffrey B Washam2, Stavros E Mountantonakis3, Shuang Li4, Matthew T Roe5, James A de Lemos5, Rohit Arora6.   

Abstract

Although cocaine ingestion may cause or contribute to myocardial infarction (MI), few contemporary data are available describing cocaine-associated MI. We describe the characteristics, management, and outcomes of patients with MI and recent cocaine use from the Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines (ACTION Registry-GWTG) program. The study population was 102,952 patients enrolled in the American College of Cardiology ACTION Registry-GWTG from July 2008 to March 31, 2010 from 460 sites across the United States. Cocaine exposure was defined as self-reported cocaine use within the last 72 hours or a positive urine test for cocaine. Demographics and medical history, presenting characteristics, treatments, and in-hospital outcomes were reported on a standard case record form. A total of 924 patients (0.9%) were cocaine positive. Compared with cocaine-negative patients, cocaine-positive patients were younger and predominantly men with fewer cardiovascular risk factors. There was a higher percentage of ST elevation myocardial infarction (STEMI) (46.3% vs 39.7%) and cardiogenic shock at presentation in the cocaine-positive group, but the percentage of multivessel coronary artery disease was lower (53.3% vs 64.5%). Beta blockers within 24 hours (85.8% vs 90.1%, p <0.0001) and drug-eluting stents (40.1% vs 68.8%, p <0.0001 in patients with non-STEMI; 27.6% vs 54.6%, p <0.0001 in patients with STEMI) were used less commonly in cocaine-positive patients. Multivariable-adjusted in-hospital mortality was similar between cocaine-positive and cocaine-negative patients (adjusted odds ratio 1.00, 95% confidence interval 0.69 to 1.44, p value = 0.98). In conclusion cocaine-positive patients with acute coronary syndrome are younger with fewer risk factors, multivessel coronary artery disease and lower drug-eluting stent and β-blocker usage. Cocaine use was not associated with in-hospital mortality.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24388623     DOI: 10.1016/j.amjcard.2013.11.023

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

1.  The implications of cocaine use and associated behaviors on adverse cardiovascular outcomes among veterans: Insights from the VA Clinical Assessment, Reporting, and Tracking (CART) Program.

Authors:  Ateka Gunja; Maggie A Stanislawski; Anna E Barón; Thomas M Maddox; Steven M Bradley; Mladen I Vidovich
Journal:  Clin Cardiol       Date:  2018-06-09       Impact factor: 2.882

2.  Cocaine and Marijuana Use Among Young Adults With Myocardial Infarction.

Authors:  Ersilia M DeFilippis; Avinainder Singh; Sanjay Divakaran; Ankur Gupta; Bradley L Collins; David Biery; Arman Qamar; Amber Fatima; Mattheus Ramsis; Daniel Pipilas; Roxanna Rajabi; Monica Eng; Jon Hainer; Josh Klein; James L Januzzi; Khurram Nasir; Marcelo F Di Carli; Deepak L Bhatt; Ron Blankstein
Journal:  J Am Coll Cardiol       Date:  2018-03-10       Impact factor: 24.094

3.  Improvement in clinical outcomes of patients with heart failure and active cocaine use after β-blocker therapy.

Authors:  Persio D Lopez; Adedoyin Akinlonu; Tuoyo O Mene-Afejuku; Carissa Dumancas; Mohammed Saeed; Eder H Cativo; Ferdinand Visco; Savi Mushiyev; Gerald Pekler
Journal:  Clin Cardiol       Date:  2018-04-17       Impact factor: 2.882

4.  Patient registries for substance use disorders.

Authors:  Betty Tai; Lian Hu; Udi E Ghitza; Steven Sparenborg; Paul VanVeldhuisen; Robert Lindblad
Journal:  Subst Abuse Rehabil       Date:  2014-07-24

5.  In-Hospital and Long-Term Outcomes of Beta-Blocker Treatment in Cocaine Users: A Systematic Review and Meta-analysis.

Authors:  Doosup Shin; Eun Sun Lee; Chandrashekar Bohra; Kullatham Kongpakpaisarn
Journal:  Cardiol Res       Date:  2019-02-24

6.  The current practice for cocaine-associated chest pain in the Netherlands.

Authors:  Femke M J Gresnigt; Nanda P Gubbels; Robert K Riezebos
Journal:  Toxicol Rep       Date:  2020-12-18

7.  Effects of Substance Use Disorder on In-Hospital Outcomes of Young Patients Presenting With a Cardiovascular Event: A Nationwide Analysis.

Authors:  Ahmed Brgdar; John Gharbin; Ayman Elawad; Jin Yi; Jacob Sanchez; Adey Bishaw; Mohamed E Taha; Edmund Essah Ameyaw; Norman Allen; Mehrotra Prafulla
Journal:  Cureus       Date:  2022-03-01

Review 8.  Cardiovascular and Hepatic Toxicity of Cocaine: Potential Beneficial Effects of Modulators of Oxidative Stress.

Authors:  Manuela Graziani; Letizia Antonilli; Anna Rita Togna; Maria Caterina Grassi; Aldo Badiani; Luciano Saso
Journal:  Oxid Med Cell Longev       Date:  2015-12-28       Impact factor: 6.543

Review 9.  Acute and Chronic Effects of Cocaine on Cardiovascular Health.

Authors:  Sung Tae Kim; Taehwan Park
Journal:  Int J Mol Sci       Date:  2019-01-29       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.